BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38694706)

  • 21. Radiomics modelling in rectal cancer to predict disease-free survival: evaluation of different approaches.
    Tibermacine H; Rouanet P; Sbarra M; Forghani R; Reinhold C; Nougaret S;
    Br J Surg; 2021 Oct; 108(10):1243-1250. PubMed ID: 34423347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models.
    Li Z; Ma X; Shen F; Lu H; Xia Y; Lu J
    BMC Med Imaging; 2021 Feb; 21(1):30. PubMed ID: 33593304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Liu Z; Zhang XY; Shi YJ; Wang L; Zhu HT; Tang Z; Wang S; Li XT; Tian J; Sun YS
    Clin Cancer Res; 2017 Dec; 23(23):7253-7262. PubMed ID: 28939744
    [No Abstract]   [Full Text] [Related]  

  • 24. Machine learning-based multiparametric MRI radiomics for predicting poor responders after neoadjuvant chemoradiotherapy in rectal Cancer patients.
    Wang J; Chen J; Zhou R; Gao Y; Li J
    BMC Cancer; 2022 Apr; 22(1):420. PubMed ID: 35439946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer.
    Jayaprakasam VS; Paroder V; Gibbs P; Bajwa R; Gangai N; Sosa RE; Petkovska I; Golia Pernicka JS; Fuqua JL; Bates DDB; Weiser MR; Cercek A; Gollub MJ
    Eur Radiol; 2022 Feb; 32(2):971-980. PubMed ID: 34327580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI-Based Radiomic Models Outperform Radiologists in Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Wen L; Liu J; Hu P; Bi F; Liu S; Jian L; Zhu S; Nie S; Cao F; Lu Q; Yu X; Liu K
    Acad Radiol; 2023 Sep; 30 Suppl 1():S176-S184. PubMed ID: 36739228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
    Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of Pre- and Post-radio-chemotherapy MRI Texture Features With Tumor Response in Rectal Cancer.
    Paiar F; Gabelloni M; Pasqualetti F; Cocuzza P; Montrone S; Arena C; Faggioni L; Falaschi Z; Del Secco L; Alberich-Bayarri A; Bonmati LM; Neri E
    Anticancer Res; 2023 Feb; 43(2):781-788. PubMed ID: 36697103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endorectal ultrasound radiomics in locally advanced rectal cancer patients: despeckling and radiotherapy response prediction using machine learning.
    Abbaspour S; Abdollahi H; Arabalibeik H; Barahman M; Arefpour AM; Fadavi P; Ay M; Mahdavi SR
    Abdom Radiol (NY); 2022 Nov; 47(11):3645-3659. PubMed ID: 35951085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Best MRI predictors of complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Sathyakumar K; Chandramohan A; Masih D; Jesudasan MR; Pulimood A; Eapen A
    Br J Radiol; 2016; 89(1060):20150328. PubMed ID: 26828967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.
    Feng L; Liu Z; Li C; Li Z; Lou X; Shao L; Wang Y; Huang Y; Chen H; Pang X; Liu S; He F; Zheng J; Meng X; Xie P; Yang G; Ding Y; Wei M; Yun J; Hung MC; Zhou W; Wahl DR; Lan P; Tian J; Wan X
    Lancet Digit Health; 2022 Jan; 4(1):e8-e17. PubMed ID: 34952679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
    Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MR-based artificial intelligence model to assess response to therapy in locally advanced rectal cancer.
    Ferrari R; Mancini-Terracciano C; Voena C; Rengo M; Zerunian M; Ciardiello A; Grasso S; Mare' V; Paramatti R; Russomando A; Santacesaria R; Satta A; Solfaroli Camillocci E; Faccini R; Laghi A
    Eur J Radiol; 2019 Sep; 118():1-9. PubMed ID: 31439226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative prediction of perineural invasion of rectal cancer based on a magnetic resonance imaging radiomics model: A dual-center study.
    Liu Y; Sun BJ; Zhang C; Li B; Yu XX; Du Y
    World J Gastroenterol; 2024 Apr; 30(16):2233-2248. PubMed ID: 38690027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI radiomics signature to predict lymph node metastasis after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
    Fang Z; Pu H; Chen XL; Yuan Y; Zhang F; Li H
    Abdom Radiol (NY); 2023 Jul; 48(7):2270-2283. PubMed ID: 37085730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiphase and multiparameter MRI-based radiomics for prediction of tumor response to neoadjuvant therapy in locally advanced rectal cancer.
    Huang H; Han L; Guo J; Zhang Y; Lin S; Chen S; Lin X; Cheng C; Guo Z; Qiu Y
    Radiat Oncol; 2023 Oct; 18(1):179. PubMed ID: 37907928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-task reconstruction network for synthetic diffusion kurtosis imaging: Predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Ma Q; Liu Z; Zhang J; Fu C; Li R; Sun Y; Tong T; Gu Y
    Eur J Radiol; 2024 May; 174():111402. PubMed ID: 38461737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment.
    Ciolina M; Caruso D; De Santis D; Zerunian M; Rengo M; Alfieri N; Musio D; De Felice F; Ciardi A; Tombolini V; Laghi A
    Radiol Med; 2019 May; 124(5):331-338. PubMed ID: 30560501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodality radiomics prediction of radiotherapy-induced the early proctitis and cystitis in rectal cancer patients: a machine learning study.
    Abbaspour S; Barahman M; Abdollahi H; Arabalibeik H; Hajainfar G; Babaei M; Iraji H; Barzegartahamtan M; Ay MR; Mahdavi SR
    Biomed Phys Eng Express; 2023 Dec; 10(1):. PubMed ID: 37995359
    [No Abstract]   [Full Text] [Related]  

  • 40. Radiomics-enhanced early regression index for predicting treatment response in rectal cancer: a multi-institutional 0.35 T MRI-guided radiotherapy study.
    Boldrini L; Chiloiro G; Cusumano D; Yadav P; Yu G; Romano A; Piras A; Votta C; Placidi L; Broggi S; Catucci F; Lenkowicz J; Indovina L; Bassetti MF; Yang Y; Fiorino C; Valentini V; Gambacorta MA
    Radiol Med; 2024 Apr; 129(4):615-622. PubMed ID: 38512616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.